Showing results (401-410 of 477) with videos related to
Sort By:
Pageof 48
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.Circulation. Cardiovascular Interventions|June 16, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary InterventionJ J Coughlan, Alp Aytekin, Gjin Ndrepepa, et al.Circulation|January 30, 2020
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval StudiesSabato Sorrentino, Bimmer E Claessen, Rishi Chandiramani, et al.Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 6, 2016
Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trialGeorg Fuernau, Karl Fengler, Steffen Desch, et al.Circulation. Cardiovascular Interventions|December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsAkiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.JACC. Cardiovascular Interventions|July 21, 2018
Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium)Michael Joner, Tobias Koppara, Robert A Byrne, et al.Journal of the American Heart Association|April 1, 2020
Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval StudiesRishi Chandiramani, Davide Cao, Bimmer E Claessen, et al.The American Journal of Cardiology|September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.Pageof 48